See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI102.35▲ 2.90%
← DEMANT page
XStocksXray
Market X-Ray report · 22 October 2026

Demant A/S (DEMANT)

Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026

Key indicators

Last closeDKK 354.00
52-week range175.00 – 364.00
Return, 1 month / 3 months+14.6% / +30.4%
Return, 1 year / 3 years+49.9% / +34.4%
TrendUptrend
RSI (14)68
Volatility (1 year)33.7%
Worst drawdown (1 year)-26.8%
Average daily value traded95.64M DKK
Dividend yield–

Market X-Ray price-based

78/ 100 · High confidence · ahead of 96% of stocks on this exchange
Trend92
Momentum90
Stability (higher is calmer)45
Liquidity90
Income–

Five-year price chart navy: price · brown: 200-day average

1612172723273832021-102023-012024-042025-072026-10

About the company

Demant A/S is a hearing healthcare company based in Denmark. It develops and makes hearing aids, which it sells under several brand names to hearing care professionals and through its own retail clinics. The company also supplies diagnostic instruments and equipment used by audiologists, and it runs hearing care centres in many countries. Its customers include audiology clinics, hospitals and people with hearing loss who buy devices and related services directly from its retail outlets.

Demant A/S trades under the code DEMANT on the Copenhagen Exchange in Denmark, with its price quoted in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Demant A/S (DEMANT) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 354.00 on 22 October 2026.

Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 7 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 49.9% and over the last three months it rose 30.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Demant A/S (DEMANT)

The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange

Lens and metricValueScoreReading
Trend92 · StrongTrading above its long-term averages and near its highs.
Above 200-day average41.9%
From 52-week high-2.7%
Momentum90 · StrongRising faster than most stocks on this exchange.
3-month return30.4%
6-month return66.2%
12-month return, skipping the last month30.8%
Stability (higher is calmer)45 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)33.7%
Worst drawdown, 1 year (smaller is calmer)-26.8%
Liquidity90 · StrongTrades actively.
Average daily value traded95.64M DKK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−1.4%
1 month+14.6%
3 months+30.4%
6 months+66.2%
1 year+49.9%
3 years+34.4%
5 years+15.3%

Signals

50-day / 200-day average310.99 / 249.41
Golden / death cross (60 days)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)7.64

Technical summary

DailyStrongly bullish11 bullish · 4 neutral · 1 bearish
WeeklyStrongly bullish11 bullish · 0 neutral · 1 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026